CN117716037A - 含有人源化抗体的试剂 - Google Patents

含有人源化抗体的试剂 Download PDF

Info

Publication number
CN117716037A
CN117716037A CN202280052194.2A CN202280052194A CN117716037A CN 117716037 A CN117716037 A CN 117716037A CN 202280052194 A CN202280052194 A CN 202280052194A CN 117716037 A CN117716037 A CN 117716037A
Authority
CN
China
Prior art keywords
antibody
humanized antibody
humanized
crp
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280052194.2A
Other languages
English (en)
Chinese (zh)
Inventor
石川晴登
山本公隆
泉谷宪幸
小笠原大辅
若林雪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Denka Co Ltd
Original Assignee
Denka Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denka Co Ltd filed Critical Denka Co Ltd
Publication of CN117716037A publication Critical patent/CN117716037A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN202280052194.2A 2021-07-26 2022-07-26 含有人源化抗体的试剂 Pending CN117716037A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021121812 2021-07-26
JP2021-121812 2021-07-26
PCT/JP2022/028698 WO2023008404A1 (ja) 2021-07-26 2022-07-26 ヒト化抗体を含む試薬

Publications (1)

Publication Number Publication Date
CN117716037A true CN117716037A (zh) 2024-03-15

Family

ID=85086990

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280052194.2A Pending CN117716037A (zh) 2021-07-26 2022-07-26 含有人源化抗体的试剂

Country Status (7)

Country Link
US (1) US20250102496A1 (https=)
EP (1) EP4372009A4 (https=)
JP (1) JPWO2023008404A1 (https=)
KR (1) KR20240005839A (https=)
CN (1) CN117716037A (https=)
TW (1) TW202311743A (https=)
WO (1) WO2023008404A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025135074A1 (ja) * 2023-12-18 2025-06-26 デンカ株式会社 標的抗原の測定方法並びにそれに用いる抗体、不溶性粒子及び標的抗原測定用キット

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07260786A (ja) * 1994-03-18 1995-10-13 Tosoh Corp ヒト由来一定領域を有する抗体を使用する免疫測定方法
WO2005058359A2 (en) * 2003-12-15 2005-06-30 Theralogic Gmbh & Co. Kg Method for neutralizing effects of crp for increasing immune reactions to hiv
ES2595638T3 (es) * 2007-09-26 2017-01-02 Chugai Seiyaku Kabushiki Kaisha Método para modificar el punto isoeléctrico de un anticuerpo mediante la sustitución de aminoácidos en una CDR
EP2050764A1 (en) * 2007-10-15 2009-04-22 sanofi-aventis Novel polyvalent bispecific antibody format and uses thereof
JP4657328B2 (ja) 2008-07-18 2011-03-23 栄研化学株式会社 免疫反応干渉物質の除去方法
KR20110112307A (ko) * 2008-11-25 2011-10-12 앨더 바이오파마슈티컬즈, 인코포레이티드 알부민을 상승시키고 및／또는 ｃｒｐ를 낮추는 ｉｌ­６의 길항제
ES2871648T7 (es) 2014-09-17 2024-10-16 Univ Cornell Identificación del estado de la fertilidad masculina mediante la determinación de la capacitación del esperma
CA3013522A1 (en) * 2016-02-05 2017-08-10 Dana Genetic A/S Method for diagnosing and treating cancer using antibodies that bind to c1 inactivator, c reactive protein and/or complement component c4

Also Published As

Publication number Publication date
KR20240005839A (ko) 2024-01-12
US20250102496A1 (en) 2025-03-27
JPWO2023008404A1 (https=) 2023-02-02
TW202311743A (zh) 2023-03-16
WO2023008404A1 (ja) 2023-02-02
EP4372009A1 (en) 2024-05-22
EP4372009A4 (en) 2025-06-11

Similar Documents

Publication Publication Date Title
US11372001B2 (en) Anti-human IgG4 monoclonal antibody and methods of making and using same
JP3602135B2 (ja) 抗体クラス特異的干渉除去剤
JP2011510291A (ja) 治療用抗体に対する抗体を検出する方法およびキット
CN111269314A (zh) 一种抗ck18单克隆抗体及其应用
CN117716037A (zh) 含有人源化抗体的试剂
US20100009389A1 (en) Method of Making and Using Versatile Positive Controls and Antibody Detection Assays
JP7626753B2 (ja) Ｆｃ領域の一部を欠損した抗体を含む試薬
KR102569269B1 (ko) 피검 대상의 검출 방법 및 그것을 위한 면역 측정 기구 및 모노클로널 항체
KR102767384B1 (ko) 마이코플라즈마 뉴모니에의 면역 측정 방법 및 면역 측정 기구
CN111727200B (zh) 用于检测弯曲杆菌属细菌的抗体和测试设备
CN110997727B (zh) 用于确定微型猪样品中抗药物抗体的方法
JP7834214B2 (ja) 標的抗原の測定方法並びにそれに用いる不溶性粒子及び標的抗原測定用キット
JP7366411B2 (ja) ヒトαディフェンシンＨＤ５を検出する方法及びキット、並びにこれらにおいて用いられる抗体
CN110655580A (zh) 一种杂交瘤细胞株及其用途
JP5448424B2 (ja) ヒトＩｇＧのＦｃを含有するタンパク質の測定試薬
JPWO2019167874A1 (ja) Ａｐｏａ４に対するモノクローナル抗体、免疫学的測定方法及び測定用キット
Phillips Affinity chromatography in antibody and antigen purification
CN121285662A (zh) 高通量Fab抗体片段生成和排序
WO2025249551A1 (ja) 二重特異性抗体のミスペア軽鎖交換体の定量方法
CN121319157A (zh) 抗猪繁殖与呼吸综合征病毒gp2蛋白的抗体及其应用
JP2026509483A (ja) 高親和性を有する抗体分子を得るための方法
CN121591882A (zh) 抗gp2蛋白的抗体及其制备方法与应用
CN121319156A (zh) 抗猪繁殖与呼吸综合征病毒gp3蛋白的抗体及其应用
JP2024026911A (ja) 標的抗原の測定方法並びにそれに用いる不溶性粒子及び標的抗原測定用キット
HK40031146B (zh) 抗人igg4单克隆抗体及利用该抗体的人igg4测定试剂

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination